COMMUNIQUÉ DE PRESSE publié le 22/10/2025 à 09:00, il y a 11 mois 12 jours Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRÈVE publiée le 16/10/2025 à 11:10, il y a 11 mois 18 jours Andera Partners co-dirige une levée de fonds de série A de 105 millions d'euros pour Adcytherix Investissement Andera Partners Traitements Contre Le Cancer Adcytherix BioDiscovery 7
BRÈVE publiée le 16/10/2025 à 11:10, il y a 11 mois 18 jours Andera Partners Co-Leads €105 Million Series A for Adcytherix Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
COMMUNIQUÉ DE PRESSE publié le 16/10/2025 à 11:05, il y a 11 mois 18 jours Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRÈVE publiée le 15/10/2025 à 11:15, il y a 11 mois 19 jours Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
BRÈVE publiée le 15/10/2025 à 11:15, il y a 11 mois 19 jours Andera Partners s'engage dans la série C de Tubulis, d'un montant de 308 millions d'euros, pour le développement d'ADC Andera Partners Tubulis Développement ADC Financement De Série C Expansion Clinique
COMMUNIQUÉ DE PRESSE publié le 15/10/2025 à 11:10, il y a 11 mois 19 jours Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRÈVE publiée le 12/06/2025 à 10:05, il y a 1 année 3 mois Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
BRÈVE publiée le 12/06/2025 à 10:05, il y a 1 année 3 mois Andera Partners élargit sa stratégie de financement mezzanine sans sponsor avec des nominations clés Développement International Andera Partners Marchés Européens Nominations Stratégiques Mezzanine Sans Sponsor
COMMUNIQUÉ DE PRESSE publié le 12/06/2025 à 10:00, il y a 1 année 3 mois Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing
Publié le 02/10/2026 à 17:45, il y a 1 jour 2 heures Information concerning the total number of voting rights and shares 2026 09 30
Publié le 02/10/2026 à 17:45, il y a 1 jour 2 heures Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Publié le 02/10/2026 à 17:35, il y a 1 jour 2 heures Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Publié le 02/10/2026 à 17:30, il y a 1 jour 2 heures Aéroports de Paris SA - Calendrier financier 2027
Publié le 03/10/2026 à 02:35, il y a 17 heures 14 minutes Jaguar Health Announces a Special Stock Dividend
Publié le 02/10/2026 à 13:50, il y a 1 jour 5 heures AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Publié le 02/10/2026 à 13:00, il y a 1 jour 6 heures Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Publié le 02/10/2026 à 13:00, il y a 1 jour 6 heures Alaska Energy Metals Appoints Independent Director, Thomas Benson
Publié le 03/10/2026 à 15:45, il y a 4 heures 4 minutes Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Publié le 02/10/2026 à 23:55, il y a 19 heures 54 minutes IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Publié le 02/10/2026 à 20:23, il y a 23 heures 25 minutes EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Publié le 02/10/2026 à 19:46, il y a 1 jour innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Publié le 02/10/2026 à 19:00, il y a 1 jour INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF